Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic

Updated 06/21/2024

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06116916
Study type	Interventional
Source	Kyowa Kirin Co., Ltd.
Contact	Kyowa Kirin, Inc.
Phone	+1-609-919-1100
Email	kkd.clintrial.82@kyowakirin.com
Status	Recruiting
Phase	Phase 2
Start date	January 9, 2024
Completion date	December 2025

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01702441` - Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema	Phase 1/Phase 2
	Active, not recruiting	`NCT04543331` - Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema
	Completed	`NCT02424019` - Phase 4 IOP Signals Associated With ILUVIEN®	Phase 4
	Completed	`NCT02633852` - Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema	Phase 4
	Completed	`NCT04857996` - Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)	Phase 2
	Recruiting	`NCT05919693` - A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)	Phase 1/Phase 2
	Completed	`NCT04739306` - Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema	Phase 3
	Completed	`NCT02050828` - The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema	Phase 2
	Recruiting	`NCT03859245` - Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention	N/A
	Completed	`NCT02585401` - Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada	N/A
	Terminated	`NCT02080091` - Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies	N/A
	Terminated	`NCT04697758` - Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema	Phase 1/Phase 2
	Terminated	`NCT00936520` - SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy	Phase 1
	Not yet recruiting	`NCT06398080` - An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting
	Active, not recruiting	`NCT05989126` - Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)	Phase 3